NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
01 4NanoAlvand
02 3Apotex Inc
03 10Incyte Corporation
04 45Novartis Pharmaceuticals Corporation
05 3Novartis South Africa (Pty) Ltd
06 2ORIFARM GROUP AS
01 1CREAM
02 1CREAM;TOPICAL
03 3Cream
04 2Oral Solution
05 1Syrup
06 3TAB
07 4TABLET
08 3TABLET; ORAL
09 5TABLET;ORAL
10 22Tablet
11 22Blank
01 6Allowed
02 6Approved
03 5Authorized
04 5Marketed
05 2Not Marketed
06 3Originator
07 5Prescription
08 6RX
09 29Blank
01 5JAKAFI
02 4JAKAVI
03 39Jakavi
04 1Jakavi 15 mg
05 1Jakavi 20 mg
06 1Jakavi 5 mg
07 2OPZELURA
08 2Opzelura
09 1Opzelura g
10 4Relata
11 3Ruxolitinib
12 4Strong
01 22Australia
02 5Canada
03 4Iran
04 7Norway
05 3South Africa
06 5Spain
07 6Sweden
08 6Switzerland
09 9USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : USA
Brand Name : Ruxolitinib
Dosage Form : TABLET; ORAL
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 219660
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : Ruxolitinib
Dosage Form : TABLET; ORAL
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number : 219660
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : Ruxolitinib
Dosage Form : TABLET; ORAL
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 219660
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OPZELURA
Dosage Form : CREAM;TOPICAL
Dosage Strength : EQ 1.5% BASE
Packaging :
Approval Date : 2021-09-21
Application Number : 215309
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Opzelura g
Dosage Form : Cream
Dosage Strength : 15mg
Packaging :
Approval Date : 30/01/2025
Application Number : 69443
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 15mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 20mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Oral Solution
Dosage Strength : 5mg/ml
Packaging :
Approval Date : 27/03/2025
Application Number : 69722
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 03/10/2014
Application Number : 20140311000017
Regulatory Info : Approved
Registration Country : Sweden
